DS
BBLG

DRW Securities’s Bone Biologics BBLG Stock Holding History

DRW Securities’s Portfolio BBLG Stock Details BBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,576
Closed -$34.2K – 1295
2025
Q4 		$34.2K Buy
23,576
+12,549
+114% +$25K ﹤0.01% 1143
2025
Q3 		$30.8K Buy
+11,027
New +$27.9K ﹤0.01% 1240

Other funds holding BBLG

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DRW Securities's BBLG Position: Q1 2026 in Review

DRW Securities sold out of Bone Biologics (BBLG) in Q1 2026, closing a stake of 23,576 shares — an estimated $34.2K sold.

DRW Securities first reported a position in BBLG in Q3 2025 and held it in 2 quarters. The position peaked at $34.2K in Q4 2025. 3 funds tracked by Wall St. Rank hold BBLG as of Q1 2026.

  • DRW Securities reported no remaining Bone Biologics position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 23,576 Bone Biologics shares in Q1 2026, an estimated $34.2K.
  • DRW Securities first reported a position in Bone Biologics in Q3 2025 and held it in 2 quarters.
  • DRW Securities's Bone Biologics position peaked at $34.2K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Bone Biologics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.